AU2008266971B2 - Topical composition for treating pain - Google Patents

Topical composition for treating pain Download PDF

Info

Publication number
AU2008266971B2
AU2008266971B2 AU2008266971A AU2008266971A AU2008266971B2 AU 2008266971 B2 AU2008266971 B2 AU 2008266971B2 AU 2008266971 A AU2008266971 A AU 2008266971A AU 2008266971 A AU2008266971 A AU 2008266971A AU 2008266971 B2 AU2008266971 B2 AU 2008266971B2
Authority
AU
Australia
Prior art keywords
pain
patient
gel
formulation
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2008266971A
Other languages
English (en)
Other versions
AU2008266971A1 (en
Inventor
Arnold L. Oronsky
Bryan T. Oronsky
Neil Charles Oronsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epicentrx Inc
Original Assignee
Epicentrx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicentrx Inc filed Critical Epicentrx Inc
Publication of AU2008266971A1 publication Critical patent/AU2008266971A1/en
Assigned to COMGENRX, INC. reassignment COMGENRX, INC. Request for Assignment Assignors: XVASIVE, INC.
Application granted granted Critical
Publication of AU2008266971B2 publication Critical patent/AU2008266971B2/en
Assigned to EPICENTRX, INC. reassignment EPICENTRX, INC. Request for Assignment Assignors: COMGENRX, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AU2008266971A 2007-06-12 2008-06-11 Topical composition for treating pain Active AU2008266971B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94355207P 2007-06-12 2007-06-12
US60/943,552 2007-06-12
US11/851,241 US9511016B2 (en) 2007-06-12 2007-09-06 Topical composition for treating pain
US11/851,241 2007-09-06
PCT/US2008/007354 WO2008156646A1 (en) 2007-06-12 2008-06-11 Topical composition for treating pain

Publications (2)

Publication Number Publication Date
AU2008266971A1 AU2008266971A1 (en) 2008-12-24
AU2008266971B2 true AU2008266971B2 (en) 2014-06-26

Family

ID=40132558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008266971A Active AU2008266971B2 (en) 2007-06-12 2008-06-11 Topical composition for treating pain

Country Status (6)

Country Link
US (4) US9511016B2 (enExample)
EP (1) EP2164476A1 (enExample)
JP (1) JP2010531298A (enExample)
CN (1) CN101842090A (enExample)
AU (1) AU2008266971B2 (enExample)
WO (1) WO2008156646A1 (enExample)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20050271746A1 (en) * 2004-05-18 2005-12-08 Abbott Chun L Topical treatments for abnormal biological conditions and method of topically treating such conditions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20090188521A1 (en) * 2008-01-17 2009-07-30 Evazynajad Ali M Dental Floss Formed from Botanic and Botanically Derived Fiber
WO2009158667A2 (en) * 2008-06-27 2009-12-30 Comgenrx, Inc. Povidone compositions for wound healing
CA2898535C (en) * 2008-07-18 2016-05-17 Biomod Concepts Inc. Articles of manufacture releasing an active ingredient
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
EP2428211A4 (en) * 2009-05-07 2013-04-03 Moon & J Inc PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURAL DAMAGE AND NEUROLOGICAL DISEASES
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
SG178502A1 (en) 2009-08-21 2012-03-29 Targeted Delivery Technologies Ltd Vesicular formulations
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8894630B2 (en) 2009-11-13 2014-11-25 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8439896B2 (en) * 2009-11-13 2013-05-14 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8888761B2 (en) * 2009-11-13 2014-11-18 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
US20130165468A1 (en) * 2010-05-13 2013-06-27 Afgin Pharma, Llc Topical peripheral neuro-affective (tpna) therapy
CN102021824B (zh) * 2010-11-17 2011-12-07 南通醋酸纤维有限公司 一种纺丝油剂用抑菌型乳化剂
US11344505B1 (en) 2010-12-01 2022-05-31 Gowey Research Group, Pllc Herbal formulations of carnivorous plants and methods for treating inflammation
US10758578B2 (en) 2010-12-01 2020-09-01 Gowey Research Group PLLC Herbal formulations of carnivorous plants and methods for treating inflammation
US10744151B1 (en) 2010-12-01 2020-08-18 Gowey Research Group PLLC Micro-RNA profiling, compositions, and methods of treating diseases
CA2819512C (en) * 2010-12-01 2020-09-29 Brandie Gowey Novel topical composition of sarracenia purpurea (pitcher plant)
US11414663B2 (en) 2010-12-01 2022-08-16 Gowey Research Group, Pllc Micro-RNA profiling, compositions, and methods of treating diseases
US12318420B2 (en) 2010-12-01 2025-06-03 Gowey Research Group, Pllc Herbal formulations of carnivorous plants and methods for treating inflammation
SG193970A1 (en) * 2011-01-24 2013-11-29 Anterios Inc Nanoparticle compositions
ES2742273T3 (es) * 2011-02-15 2020-02-13 Aclaris Therapeutics Inc Composiciones de crema farmacéuticas de oximetazolina para tratar los síntomas de la rosácea
EP2578190A1 (en) * 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Intraocular injection device
US20130190277A1 (en) * 2012-01-25 2013-07-25 Joel Bain HERRON Paraffin Wax Embedded Drug Delivery System
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
EP2968652B1 (en) 2013-03-13 2020-07-22 Avery Dennison Corporation Improving adhesive properties
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US12318406B2 (en) * 2013-03-15 2025-06-03 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
WO2015164658A1 (en) * 2014-04-24 2015-10-29 Sympara Medical, Inc. Methods and devices for treating hypertension
US10653738B2 (en) * 2014-07-22 2020-05-19 Meridian Research and Development Inc. Topical medications for bruises and burns
CN104491326A (zh) * 2014-12-09 2015-04-08 郑志保 一种用于推拿治疗腰椎间盘突出症的中药
EP3238717B1 (en) * 2014-12-22 2019-08-28 Hisamitsu Pharmaceutical Co., Inc. Cataplasm
CN104491228A (zh) * 2015-01-04 2015-04-08 杨茹芹 一种治疗肾阳衰惫型癃闭的中药组合物
EP3258928A4 (en) * 2015-02-18 2018-10-10 Tersus Life Sciences, LLC Methods for improving joint function
CN104825808A (zh) * 2015-04-23 2015-08-12 张莉 一种治疗慢性咽炎的中药组合物及其制备方法
CN104784502A (zh) * 2015-05-13 2015-07-22 戴惠英 一种治疗高脂血症的药剂
HRP20210903T1 (hr) 2015-06-30 2021-09-17 Sequessome Technology Holdings Limited Miješane formulacije
US20180214482A1 (en) * 2015-08-13 2018-08-02 Sense Technology, Inc. Method of enabling muscle relaxation
US10286095B2 (en) 2015-09-11 2019-05-14 Olson Ip Technologies, Inc. Travel kit
SG11201805942UA (en) 2016-01-11 2018-08-30 Epicentrx Inc Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
CN105686100B (zh) * 2016-01-25 2017-08-01 邱定武 一种治疗足跟痛的袜底及其制备工艺
CN105559157B (zh) * 2016-01-25 2017-06-30 邱定武 一种治疗趾腱筋膜炎的袜底及其制备工艺
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11260035B2 (en) * 2016-10-12 2022-03-01 Ps Therapies Ltd Topical compositions and methods of use thereof
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
WO2019164593A2 (en) 2018-01-08 2019-08-29 Epicentrx, Inc. Methods and compositions utilizing rrx-001 combination therapy for radioprotection
WO2019164594A2 (en) * 2018-01-08 2019-08-29 Epicentrx, Inc. METHODS AND COMPOSITIONS UTILIZING RRx-001 FOR RADIOPROTECTION
US10279176B1 (en) * 2018-06-11 2019-05-07 First Step Holdings, Llc Method and apparatus for increasing absorption of medications and cosmeceuticals through the skin of the user
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
CN109999353A (zh) * 2019-04-19 2019-07-12 广东泰宝医疗科技股份有限公司 一种远红外温感理疗贴及其制备方法
CN118286372A (zh) * 2019-08-23 2024-07-05 太康海恩药业有限公司 祛风散寒热敷包、组合物及其加工方法
US12138414B2 (en) 2020-02-10 2024-11-12 Icy Beauty Inc. Mask assembly for face
EP3967308A1 (en) * 2020-09-11 2022-03-16 Assistance Publique, Hopitaux De Paris Mepyramine for use in the topical treatment of neuropathic pain
JP2026502695A (ja) 2023-01-26 2026-01-23 インシグニア・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニー 変形性関節症の処置のための医薬組成物
US20240358631A1 (en) * 2023-04-26 2024-10-31 ProVEDA Corporation Topical formulations
US12133863B1 (en) * 2023-06-07 2024-11-05 King Saud University Green synthesis of silver nanoparticles encapsulated in a nanostructured lipid carrier
CN117338990A (zh) * 2023-11-17 2024-01-05 福建同安堂生物科技有限公司 聚乙二醇膏状敷料的生产工艺
CN120131482B (zh) * 2025-02-14 2026-02-06 广东袋鼠妈妈集团有限公司 一种护臀膏及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017695A1 (en) * 1992-03-12 1993-09-16 Smooth Contours, Inc. Diagnosis and treatment of various neuralgias
WO2001087234A2 (en) * 2000-05-12 2001-11-22 Supratek Pharma Inc. Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
US20050123619A1 (en) * 2003-12-09 2005-06-09 Farrell Shannon L. Mixture of and method of making a trancutaneous pain relief composition

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4361585A (en) 1979-05-03 1982-11-30 Roy Edwards Method of treatment to relieve pain in muscles or bones
CA1319613C (en) * 1986-10-07 1993-06-29 Gevork Minaskanian Penetration enhancers for transdermal delivery of systemic agents
US4908387A (en) * 1988-06-06 1990-03-13 The Regents Of The University Of California Use of beta2 antagonists in the treatment of inflammatory diseases, in particular, rheumatoid arthritis
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
US5444076A (en) * 1990-11-26 1995-08-22 Roemmers S.A.I.C.F. Pharmaceutical preparation for topical application
US5294438A (en) * 1991-02-05 1994-03-15 Minnesota Mining And Manufacturing Company Lubricating and moisturizing shaving preparations
ATE157009T1 (de) * 1991-03-01 1997-09-15 Atherton Investments Ltd Therapeutische und kosmetische zusammensetzungen zur hautbehandlung
US5336486A (en) * 1991-03-28 1994-08-09 Theratech, Inc. Appetite control method
US5401728A (en) * 1992-04-02 1995-03-28 Simon; John A. Lecithin based topical liniment
DE4341139C1 (de) 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5773034A (en) * 1994-05-09 1998-06-30 Fortune Base Management, Ltd. Cutaneous rejuvenating and healing product, method for its manufacture and uses thereof
US5560910A (en) * 1994-08-26 1996-10-01 Crandall; Wilson T. Topical anti-inflammatory composition and method
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US6479074B2 (en) * 1996-10-24 2002-11-12 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US5976547A (en) * 1997-04-22 1999-11-02 Niblick Pharmaceuticals, Inc. Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
US6132762A (en) 1997-05-05 2000-10-17 Cristobal; Walter Transcutaneous application of marijuana
US5824359A (en) * 1997-06-30 1998-10-20 Becton Dickinson And Company Medical device lubricant containing lecithin
US5922332A (en) 1997-09-17 1999-07-13 Fossel; Eric T. Topical delivery of arginine to overcome pain
US5885597A (en) 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
MXPA00010103A (es) * 1998-04-16 2002-08-06 Natural Health Products Intern Metodo para el tratamiento de asma.
CH689821A5 (it) * 1998-06-22 1999-12-15 Gecomwert Anstalt Lozione tricologica ad uso topico.
HUP0102728A3 (en) * 1998-06-29 2002-12-28 Pharmaceuticals Applic Associa Methods and transdermal compositions for pain relief
DE59906392D1 (de) * 1998-12-23 2003-08-28 Esparma Gmbh Hyaluronatlyase als penetrationsförderer in topischen mitteln
US8003782B1 (en) * 1999-02-01 2011-08-23 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US20020169195A1 (en) * 2001-01-26 2002-11-14 George Kindness Combination and method of treatment of cancer utilizing a COX-2 inhibitor and an HMG-CoA inhibitor and cystine to enhance glutathione
US6528076B2 (en) * 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
US6730667B2 (en) 2001-11-26 2004-05-04 William R. Deagle Iontophoresis disc pain blocker
EP1617830A4 (en) * 2003-03-20 2008-09-24 Imagenetix Inc ESTERIFIED FATTY ACID COMPOSITION
US7713440B2 (en) * 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
WO2005041988A1 (en) 2003-10-22 2005-05-12 University Of Florida Method and composition for pain amelioration
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
WO2006130600A1 (en) 2005-05-31 2006-12-07 Warsaw Orthopedic, Inc. Compositions and methods for treating pain
US20080102107A1 (en) * 2005-12-16 2008-05-01 Valex Pharmaceuticals, Llc Compositions and methods for transdermal joint pain therapy
EP1976575A2 (en) * 2006-01-31 2008-10-08 Angiotech BioCoatings, Corp. Lubricious echogenic coatings
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US20090117059A1 (en) * 2007-08-03 2009-05-07 Oronsky Bryan T Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extracts thereof in combination with a steroid
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
WO2010009056A2 (en) * 2008-07-14 2010-01-21 Comgenrx, Inc. Pain relieving patch

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017695A1 (en) * 1992-03-12 1993-09-16 Smooth Contours, Inc. Diagnosis and treatment of various neuralgias
WO2001087234A2 (en) * 2000-05-12 2001-11-22 Supratek Pharma Inc. Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
US20050123619A1 (en) * 2003-12-09 2005-06-09 Farrell Shannon L. Mixture of and method of making a trancutaneous pain relief composition

Also Published As

Publication number Publication date
AU2008266971A1 (en) 2008-12-24
US9511016B2 (en) 2016-12-06
EP2164476A1 (en) 2010-03-24
US20080311217A1 (en) 2008-12-18
WO2008156646A1 (en) 2008-12-24
US20080311167A1 (en) 2008-12-18
CN101842090A (zh) 2010-09-22
US20080311218A1 (en) 2008-12-18
JP2010531298A (ja) 2010-09-24
US20080312583A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
AU2008266971B2 (en) Topical composition for treating pain
US6528076B2 (en) Topical compositions and methods for treating pain
US20090130048A1 (en) Topical Composition for Treating Pain
CA2685321C (en) Solubilized delivery system for topical anesthetics
JP2010531298A5 (enExample)
WO2015160941A1 (en) Topical compositions for pain relief, manufacture and use
US11007241B2 (en) Compositions for relieving pain with malkangni oil and cypriol oil as active ingredients and method of topical administration of the same
CA2940057C (en) Transdermal composition for treating pain
US9415054B2 (en) Piroxicam transdermal composition to treat plantar fasciitis
JP7025129B2 (ja) 筋痙攣治療剤
US20110045096A1 (en) Solubilized delivery system for topical anesthetics
KR20230174698A (ko) 대마종자유를 유효성분으로 함유하는 통증 치료용 약학적 조성물
CA3268830A1 (en) Combination treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
WO2024073011A1 (en) Topical compositions and methods for the treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
EP4593859A1 (en) Combination treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
WO2022254206A1 (en) Pain relief composition
US20250000827A1 (en) Topical composition for pain relief
US20130196942A1 (en) Composition for Skin Treatment
BR102019009943A2 (pt) formulação cosmética para cuidados da saúde dos pés e uso da mesma

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: COMGENRX, INC.

Free format text: FORMER APPLICANT(S): XVASIVE, INC.

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: EPICENTRX, INC.

Free format text: FORMER OWNER WAS: COMGENRX, INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 11 JUN 2019 TO 11 JAN 2020 IN WHICH TO PAY A RENEWAL FEE HAS BEEN FILED

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 11 JAN 2020